Fabio Augusto Bronzi Guimarães

Statistics

Publications

Citations

310

H-Index

Active since

2008

Affiliations

Harvard University(Current)

Brigham and Women's Hospital

AstraZeneca (Sweden)

The George Institute for Global Health

UNSW Sydney

Fabio Augusto Bronzi Guimarães is an author at Harvard University specializing in medicine, cardiovascular pharmacotherapy, and cardiovascular disease.

ORCID

Publications per year

2008–2021

Publications

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy

Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson et al. · Diabetes Care · 2020 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Impact of autologous hematopoetic stem cell transplantation on the quality of life of patients with multiple sclerosis

Fabio Augusto Bronzi Guimarães, Érika Arantes de Oliveira‐Cardoso, Ana Paula Mastropietro et al. · Arquivos de Neuro-Psiquiatria · 2010 · 22 citations · Full text

Medicine, Hematology, Neurology +15

Quality of life of patients with autoimmune diseases submitted to bone marrow transplantation: a longitudinal study

Fabio Augusto Bronzi Guimarães, Manoel Antônio dos Santos, Érika Arantes de Oliveira · Revista Latino-Americana de Enfermagem · 2008 · 17 citations · Full text

Life Sciences, Hematology, Immunology +16

Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction

Kieran F. Docherty, Pardeep S. Jhund, Brian Claggett et al. · JAMA Cardiology · 2021 · 17 citations · Full text

Medicine, Cardiology, Pharmacology +17

1–5 of 5